GENERAL5 Sept 2026
IIL says NSQ Abhayrab vials were not manufactured by its division
Indian Immunologicals has clarified that the Abhayrab anti-rabies vaccine vials a government laboratory declared NSQ (not of standard quality) and misbranded were not made by its human health division. Hospitals, clinics and patients using Abhayrab should watch for official batch-level information. The company's denial does not change any regulator's finding yet, so verify before acting.
Key Statutory Highlights
- Indian Immunologicals says the flagged Abhayrab vials were not manufactured by its human health division.
- A government laboratory had declared these anti-rabies vaccine vials NSQ and misbranded.
- The company's clarification does not overturn the regulator's finding on its own.
Actionable Advice for Taxpayers / Founders:If you stock or administer Abhayrab, confirm the affected batch details through official company or regulatory communication before taking any action.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: